Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bartlmanon May 17, 2018 6:35pm

106 Views

Post# 28049332

RE:RE:5 min to go Tomorrow BOOM TLT

Precisely Vette. If you've ever personally been through a cancer treatment or if you have a loved one who has, you are cheering this news. Yes, it's good news for us shareholders but so much more significant if you're undergoing cancer treatment of some sort. 100% effective? I like those odds. Btw, welcome to the board.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports